Robinhood gives you the tools you need to put your money in motion. You can buy or sell AbbVie and other ETFs, options, and stocks.
AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions.
Richard A. Gonzalez
North Chicago, Illinois
52 Week High
52 Week Low
FDA Strikes Off Incyte's Retifanlimab Application In Anal Cancer - Incyte Genomics
AbbVie, Lilly Atopic Dermatitis Treatments Hit With Further Delays With FDA AbbVie Inc (NYSE: ABBV) and Eli Lilly And Co (NYSE: LLY) will have to keep waiting
AbbVie Eye Drug AGN-190584 Meets Endpoints in Phase 3 Study
By Matt Grossman AbbVie Inc.'s AGN-190584 drug, a potential treatment for presbyopia, met the primary and secondary endpoints of a Phase 3 trial, the company s
$3.09 per share
Available Jul 30, Pre-Market